The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars.
about
The Role of Rituximab in Chronic Lymphocytic Leukemia Treatment and the Potential Utility of Biosimilars.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The Role of Rituximab in Chron ...... ential Utility of Biosimilars.
@en
The Role of Rituximab in Chron ...... ential Utility of Biosimilars.
@nl
type
label
The Role of Rituximab in Chron ...... ential Utility of Biosimilars.
@en
The Role of Rituximab in Chron ...... ential Utility of Biosimilars.
@nl
prefLabel
The Role of Rituximab in Chron ...... ential Utility of Biosimilars.
@en
The Role of Rituximab in Chron ...... ential Utility of Biosimilars.
@nl
P2093
P2860
P1433
P1476
The Role of Rituximab in Chron ...... ential Utility of Biosimilars.
@en
P2093
Anthony Mato
Florence Cymbalista
Ira Jacobs
Jeff Sharman
Jennifer R Brown
Pilar Nava-Parada
P2860
P356
10.1634/THEONCOLOGIST.2017-0150
P577
2017-12-06T00:00:00Z